对甲苯基硫脲和对溴苯基硫脲的晶体结构和电子结构

本文测定了对甲苯基硫脲(1)和对溴苯基硫脲(2)的晶体结构,并用 CNDO/2程序对生物活性较大的对甲苯基硫脲分子进行了量子化学计算。1属单斜晶系,空间群 P2_1/n,a=0.5618(1),b=0.8487(4),c=1.7865(3)nm,Bβ=93.53(1)°,Z=4,D。=1.298 g·cm~(-3),最终偏离因子 R=0.0396;2属单斜晶系,空间群 P 2_1/n,a=0.9096(6),b=0.8991(4),c=1.0659(8)nm,β=105.59(6)°,Z=4,D。=1.836g·Cm~(-3),最终偏离因子R=0.073。晶体结构测定结果表明,硫脲部分的四个原子组成平面三角形,苯环平面与硫脲平面的夹角分别为63.5°和68.6°。量化计算结果和晶体结构测定相吻合。     

2-(2'-吡啶基)-5-甲苯并噻唑及其二氯二乙基锡(Ⅳ)络合物的结构以及抗肿瘤有机锡络合物分子设计的展望

X-射线单晶衍射法测定了2-(2′-吡啶基)-5-甲苯并噻唑(1)及其二氯二乙基锡(Ⅳ)络合物(2)的结构。晶体(1)属单斜晶系,空间群为P2_1/n,晶胞参数a=5.808(2),b=10.283(3),c=18.373(3),β=91.48(2)°,Z=4,D_c=1.370g·cm~(-3),偏离因子R=0.047。晶体(2)属单斜晶系,空间群P2_1/c,晶胞参数a=17.271(2),b=9.411(1),c=14.015(2),β=122.98(1)°,Z=4,D_c=1.648g·cm~(-3),偏离因子R=0.047。络合物中Sn—N平均键长已达2.50。参考顺铂类药物研究经验,展望了抗肿瘤有机锡络合物发展的前景。     

铂氢化物trans-[PtH(tu)(PPh_3)_2]Cl(tu)(THF)_2(tu=SC(NH_2)_2)的结构

制得含硫脲配体的铂氢化物单晶trans-[PtH(tu)(PPh_3)_2]Cl(tu)(THF)_2,其结构测定结果为:C_(46)H_(55)N_4O_2P_2S_2ClPt M=1052.6,单斜晶系,空间群为 P2_1/c,a=12.103(1),b=21.619(3),c=20.189(4)(?),β=103.31(0)°,V=5140(2)(?)~3,Z=4,D_c=1.360g·cm~(-3),F(000)=2128,R=0.050,R_w=0.063.Pt(Ⅱ)与两个磷、一个硫脲分子的硫和一个氢相配合,形成四边形配位。     

两个具有松散配位的三核钼簇合物{Mo_3(μ_3—S)(μ—S)_3[S_2P(OEt)_2]_4(C_3H_3ON)}·CH_3CN(Ⅰ){Mo_3(μ_3—O)(μ—S)_3[S_2P(OEt)_2]_4(C_3H_3ON)}(Ⅱ)的合成和晶体结构

本文报道了两个具有松散配位的三核钼簇合物{Mo_3(μ_3—S)(μ—S)_3[S_2P(OEt)_2]_4·(C_3H_3ON)}·CH_3GN(Ⅰ)、{Mo_3(μ_3—O)(μ—S)_3[S_2P(OEt)_2]_4(C_3H_3ON)}(Ⅱ)的合成和晶体结构。簇合物(Ⅰ)属单斜晶系,空间群为P2_2/n,晶胞参数为a=16.579(3),b=16.959(2),c=16.867(2);β=94.44(1)°;v=4728 3;Z=4;D_c=1.778g·cm~(-3),用Patterson法解出结构,最终偏离因子R=0.045。簇合物(Ⅱ)属三斜晶系,空间群为P1,晶胞参数为a=13.175(4),b=13.372(6),c=16.656(3);α=117.87(4)°,β=60.09(3)°,γ=109.03(3)°;ν=2231 3;Z=2;D_c=1.798g·cm~(-3),用直接法解出结构,最终偏离因子R=0.066。两个簇合物均为以具有一个松散配位为特征的单帽三核簇,而且松散配位上均被一嘿唑五员环所占据,其主要差别在于簇合物(Ⅰ)的簇胳为Mo_3S_4,而簇合物(Ⅱ)则为一Mo_3OS_3·文中对这一“松散”配位的三核钼簇合物的活泼性进行了讨论。     

（η^5—C5H5）2Yb（THF）2的新合成方法及其晶体结构

双(环戊二烯基)镱(Ⅱ)四氢呋喃配合物(η~5-C_5H_5)_2Yb(THF)_2通过环辛二烯基钾(KC_8H_(11))还原(C_5H_5)_2YbCl·THF而得到,经元素分析、红外光谱表征,并测定了其晶体结构。配合物属单斜晶系,C2/c空间群,晶体学参数a=1.3564(4),b=0.9569(3),c=1.4747(6)nm;β=109.90(3)°;V=1.79975(118)nm~3;D_c=1.65·cm~(-3);μ_C=54.7cm~(-1)(Mo);F(000)=880,Z=4。最后一致性因子R=0.079,R_w=0.081。Yb~(2+)的配位数为8。     

N-(2-氟苯甲酰基)-N''''4-甲基苯基硫脲的结构和构型研究

合成了未见报道的N-(2-氟苯甲酰基)-N′-4-甲基苯基硫脲(FBTT),并测定了其晶体结构.晶体属三斜晶系,空间群P1,a=0.8413(5)nm,b=0.9532(5)nm,c=0.9927(6)nm,α=66.24(2)°,β=85.40(2)°,γ=72.27(2)°,V=0.693.2(7)nm3,Z=2.利用量子化学密度泛函理论,以步长为30°旋转扭角θ[N(2)-C(14)-N(1)-H(12)]得势能曲线.优化的最稳定的构型与得到的晶体结构一致.讨论了分子的构型,估算了氢键的键能.     

某些环丙烷二羧酸根合铂的结构研究

本文测定了1,1-环丙烷二羧酸根二氨合鉑(Ⅰ)、1,1-环丙烷二羧酸根二甲胺合铂(Ⅱ)以及1,1-环丙烷二羧酸根2,3-二甲基-2,3-丁二胺合鉑(Ⅲ)的晶体结构。晶体Ⅰ属正交晶系,空间群Pnma,a=6.571(2),b=9.709(3),c=14.205(5),Z=4,R=0.058;晶体Ⅱ属单斜晶系,空间群P2_1/n,a=9.648(3),b=8.720(2),c=12.770(4),β=107.12(2)°,Z=4,R=0.059;晶体Ⅲ属单斜晶系,空间群P2_1/m,a=6.494(1),b=19.638(3),c=6.606(1),β=94.44(1)°,Z=2,R=0.038。研究了三种晶体的电子结构,探讨了配位胺基对其生物活性的影响。     

Fe3(CO)12与P(NEt2)2Cl的反应--两核和三核铁羰基簇合衍生物的合成和晶体结构

Fe_3(CO)_(12)与配位基前体P(NEt_2)_2Cl反应,给出4个新的两核和三核铁羰基簇合衍生物:Fe_2(CO)_6(μ-Cl)[μ-P(NEt_2)_2](Ⅰ),Fe_2(CO)_6[μ-P(NEt_2)_2]_2(Ⅱ),Fe_3(CO)_9(μ-CO)(μ_3-PNEt_2)(Ⅲ)和Fe_3(CO)_9(μ_3-PNEt_2)[P(NEt_2)_3](Ⅳ)。在反应期间,配前体分子中的P-Cl和P-N键劈开,形成的分子片Cl、PNEt_2、P(NEt_2)_2和P(NEt_2)_3作为配体与铁羰合物重新组建成上述簇合物。利用X射线衍射法测定了它们的晶体结构。Ⅰ属三斜晶系,P1空间群,晶胞参数a=0.8745(6)nm,b=0.9601(7)nm,c=1.3996(10)nm,α=74.131(11)°,β=79.480(12)°,γ=69.727(12)°,V=1.0553(13)nm~3,D_c=1.543g·cm~(-3),Z=2,R=0.0443,wR=0.0831。Ⅱ属正交晶系,Pbcn空间群,晶胞参数a=1.0153(3)nm,b=1.7543(5)nm,c=1.6860(5)nm,V=3.0031(15)nm~3,D_c=1.394g·cm~(-3),Z=4,R=0.0519,wR=0.1035。Ⅲ属单斜晶系,P2_1/c空间群,晶胞参数a=1.0280(5)nm,b=1.2113(5)nm,c=1.9192(7)nm,β=93.560(7)°,V=2.1366(16)nm~3,D_c=1.712g·cm~(-3),Z=4。Ⅳ属单斜晶系,Cc空间群,晶胞参数a=1.5875(7)nm,b=1.0359(5)nm,C=2.1919(9)nm,β=101.266(8)°,V=3.535(3)nm~3,Dc=1.443g·cm~(-3),Z=4。Ⅰ和Ⅱ为两核铁簇,其簇骨架Fe_2PCl和Fe_2P_2呈蝶状。Ⅲ和Ⅳ     

[Cp_2ErCl(THF)]_2的晶体结构

本文报导了(Cp_2ErCl(THF)]_2的晶体结构,晶体属单斜晶系,P2_1/c空间群。晶胞参数为a=8.141(2),b=21.218(6),c=8.597(2),β=107.77(2)°;V=1414.1(6) ~3;Z=2,D_c=1.90g/cm~3,F(000)=780,μ_c=66.3cm~(-1)(MoK_a)。最终的偏离因子R=0.047,R_(to)=0.048。结构分析表明,该配合物是以两个氯离子与金属离子桥联的二聚体形式存在。四氢呋喃中的氧原子同金属离子键合,Er—O键长为2.490(6),两个环戊二烯中的所有碳原子同金属离子间的平均键长为2.649,Er-Cl=2.666(3),Er—Cl-a=2.797(3),Er-Er_a=4.42,Cl-Er-Cl_a键角为72.2°。     

大环硫氮冠醚金属配合物的研究 Ⅰ.1,4,10,13-四硫-7,16-二氮杂环十八烷的硝酸盐及氯化镍配合物的合成、晶体结构和电子结构

作为系统研究大环硫氮杂冠醚结构的一部分,合成了1,4,10,13-四硫-7,16-二氮杂环十八冠醚的硝酸盐[H_2(C_(12)H_(26)N_2S_4)(NO_3)_2]1和镍配合物[Ni(C_(12)H_(26)N_2S_4)Cl_2·4H_2O]2,并测定和计算了它们的晶体结构和电子结构.化合物1属单斜晶系,空间群 P2_1/c,a=7.936(5),b=8.866(7),c=14.756(5),β=95.33(4)°,V=1033.7~3,Z=2,D_o=1.45g·cm~(-3),μ=43.7cm~(-1),F(000)=480,最终偏离因子 R=0.059,R_w=0.059.化合物2属三斜晶系,空间群 PI,a=6.941(4),b=9.862(3),c=16.507(3)(?),α=98.78(2),β=95.52(3),γ=93.48(3)°,V=1108.3~3,Z=2,D_o=1.58g·cm~(-3),μ=14.9cm~(-1),F=(000)=556,最终偏离因子 R=0.060,R_w=0.065.晶体结构测定结果表明:化合物1与自由配体 L 相比较,N 原子的构型变化最大,在氯化镍配合物2中,四硫二氮大环发生严重扭曲,其中四个 S 和两个 N 原子在 Ni 原子周围形成八面体配位,Ni—N 距离从2.109到2.140(?),Ni—S 距离从2.370到2.435.同时,量化计算结果说明,S、N 原子与 Ni~(2+)配位时均为电子授体,且 S 对 Ni~(2+)的授电子能力,似略大于 N 原子.     

CRYSTAL STRUCTURES OF TWO DITHIOLATO-COPPER COMPLEXES (Ph_4P)Cu(BDT)_2 AND (Ph_4P)Cu(TDT)_2

<正> [(C6H5)4P]Cu(S2C6H4)2(Ⅰ),Mr = 683. 39,monoclinic,space group C2/c,a=16. 099 (4),b= 11. 913(3) ,c = 16: 715(9) A ,β=97. 13(4)°, v = 3180. 7 A3,z=4.MoKa radiation,λ= 0. 71069A ,Dc= 1. 427g/cm3,μ= 10. 1cm-1,F(000) = 1400,R=0. 061 and Rw = 0. 068 for 2189 reflections with Ⅰ>3σ(Ⅰ). [(C6H5)4P]Cu (S2C7H6)2(Ⅰ),Mr = 711. 45,monoclinic,space group C2/c,a=16. 501(6),b = 37. 461 (15),c=16. 684(4)A,β=96. 70(4)°, v= 10248. 8(46) A3,z= 12. MoKa radiation, λ= 0. 71069A,Dc=1.383g/cm3,μ=9. 45cm-1,F(000).= 4416,R= 0. 074 and Rw= 0. 078 for 2085 reflections with I>2σ(I)(1). The copper atom in the complexes is surrounded by four sulfur atoms from two dithiolato ligands in an approximate, square-plane. The average Cu-S distances of the copmplexes(Ⅰ) and (Ⅱ) are 2. 179 and 2. 178 A, respectively.     

APPLICATION OF DITHIO - MOLYBDATE IN THE SYNTHESES OF Mo-Cu CLUSTERS: SYNTHESES AND CRYSTAL STRUC-TURES OF MoOS_3(CuPPh_3)(Cu(PPh_3)_2 AND (Ph_4P)_2[Mo_2Cu_5S_6O_2-(S_2CNEt_2)_3] ·DMF

<正> The reactions of (NH4)2MoO2S2 with Cu(PPh3)3Cl in CH3CN in the air, or with CuCl, Ph4PBr, and NaS2CNEt2 in DMF under anaerobic condition, afforded the cluster complexes MoS3OCu2 (PPh3)3 (Ⅰ) and (Ph4P)2 CMo2Cu5S6O2-(S2CNEt2)33 · DMF (Ⅱ), respectively. Compound (Ⅰ), MoOS3Cu2P3C54H45(Mr = 1121. 0) , crystallizes in the triclinic, space group P1 with cell parameters a = 14. 103 (3), b = 17.906(3), c=11.503(2)(?), α=107. 76(1), β=111.81(2), γ = 74.93 (2)°, F = 2532. 9(?)3 and Z=2, Dc=1. 471 g/cm3, F (000) = 1140, μ(MoKα) = 13. 215 cm-1, final R = 0. 060 (Rw = 0.064) for 5959 independent reflections with I >3σ(Ⅰ). Complex (IⅡ), Mo2O3S12Cu5P2N4C66H77 (Mr = 1930. 67) , crystallizes in monoclinic, space group P2/c with cell parameters a = 25. 325(19) , 6 = 22. 506(9) , c =14. 066(8)(?) , β =100. 96(6)°, V =7871. 16 (?)3, Z = 4, D,= 1. 629 g/cm3, F(000) = 3904, μ(MoKα) = 20. 216 cm-1, R = 0. 097 (Rw = 0. 095) for 5677 reflections with I>3σ(Ⅰ). The core structure of complex (Ⅰ) is defective cub     

混合三烃基锡有机酸酯化合物构效关系 （Ⅰ）二环己基－甲基－2，4－二溴－β－甲基苯氧乙酸锡酯 及二环己基－甲基－2－甲氧基－4－丙烯基苯氧乙酸锡酯的晶体结构和分子结构

报道２，４－Ｂｒ２Ｃ６Ｈ３ＯＣＨ（ＣＮ３）ＣＯ２Ｓｎ（Ｃ６Ｈ１１）２ＣＵ３（１）和２－ＯＣＨ３－４－ＣＨ３ＣＨ＝ＣＨＣ６Ｈ３ＯＣＨ２ＣＯ２Ｓｎ（Ｃ６Ｈ１１）２ＣＨ３（Ｈ２Ｏ）（Ⅱ）的晶体结构和分子结构。（Ⅰ）单斜晶系，空间群Ｐ２１／ｃ，ａ＝１３．０６７（３），ｂ＝１０．５９４（３），ｃ＝１８．１５７（４），β＝１０６．９９（２）°，Ｚ＝４，Ｄｃ＝１．６７２ｇ／ｃｍ３，Ｖ＝２４０３．７３，μ＝４３．７３１ｃｍ－１，Ｍｒ＝６２２．９９，Ｆ（０００）＝１２３２；（Ⅱ）单斜晶系，空间群Ｐ２１／ｎ，ａ＝１０．４０９（１），ｂ＝　１２．５７０（２），ｃ＝２０．６６４（２），β＝８３．５１（１）°，Ｚ＝４，Ｄｃ＝１．２８１ｇ／ｃｍ３，Ｖ＝２６８６．４Ａ３，μ＝９．７６１ｃｍ－１，Ｍｒ＝５３９．２８，Ｆ（０００）＝１１２０．最后的偏离因子，化合物（Ⅰ）Ｒ＝０．０４６，Ｒω＝０．０４６；化合物（Ⅱ）Ｒ＝０．０４９，Ｒω＝０．０４７。晶体结构解析表明，化合物（Ⅰ）和（Ⅱ）中的锡均被配体的３个碳和２个氧原子配位，配位原子呈畸变三角双锥构型；化合物中的环己基均为椅式构象；化合物（Ⅱ）中，配位水分子和另一分子的羰基氧与芳环上的甲基氧?     

CRYSTAL STRUCTURE OF p—PROPIONYLCALIX [4]ARENE

<正> The title compound was synthesized by Friedel-Crafts reaction of tetrahydroxycalix [4] arene and propionyl choride, and its crystal structure was determined by X-ray diffraction technique. C10O8H40,Mr = 648. 75, triclinic, space group P1 with cell parameters, a = 9. 930(5), b = 11. 838(3), c=14. 522(7) A,α= 94. 92(3),β=102. 96(4),γ= 98. 32(3)°, V = 1635A3, Z = 2, Dc = 1. 399g/ cm3, μ(CuKa) = 3. 27cm-1, F (000) = 344. The final R = 0. 075, Rw = 0.092 for 5716 independent reflections with I>3σ(I). The crystal structure analysis shows that the molecule exists in fine cone conformation.     

Structure Studies on New Types of Macrocyclic Compounds Part Ⅵ．Crystal Structure ofCopper（Ⅱ） Complex of 5，5，7，12，12，14－hexamethyl－1，4，8，11－tetraazacyclotetradecane－N＇，N＂－diaceticacid

ＳｔｒｕｃｔｕｒｅＳｔｕｄｉｅｓｏｎＮｅｗＴｙｐｅｓｏｆＭａｃｒｏｃｙｃｌｉｃＣｏｍｐｏｕｎｄｓＰａｒｔⅥ．ＣｒｙｓｔａｌＳｔｒｕｃｔｕｒｅｏｆＣｏｐｐｅｒ（Ⅱ）Ｃｏｍｐｌｅｘｏｆ５,５,７,１２,１２,１４－ｈｅｘａｍｅｔｈｙｌ－１,４,８,１１－...     

CRYSTAL AND MOLECULAR STRUCTURE OF THE ADDUCT OF BIS [4,4,4-TRIFLUOR-1-(2-THIENYL) Butandion-1,3] COPPER (Ⅱ) WITH DIMETHYLFORMAMIDE, [Cu(TTA)_2(DMF)]

<正> [Cu(C8H4F3O2S)2(C3H7NO)], Mr = 579. 0, monoclinic, P21/c, a = 9. 4851(6), b = 26. 6574(6), c=9.2619(6) A ,β=96.08(3)°, V = 2328.7A3, Z=4, Dc=1. 65gcm-3, μ(MoKa) = 7. 2cm-1, F (000) = 1172, MoKa radiation, final R = 0. 074 and Rw = 0. 068 for 1841 reflections with I≥3σ(Ⅰ). The Cu(Ⅱ) atom is coordinated by five oxygen atoms, one of which from DMF is in the axial position, to form a square pyramidal geometry. That the thenoyl groups in the ligands take the cis-form around the Cu(Ⅱ) atom is explained by the hydrogen bonding effect.     

CRYSTAL STRUCTURE OF CHLORO-([(N,N-dimethylamino)methyl]-ferrocene-2 C,N)(pyridine)palladium(Ⅱ)

<正> C18H21ClN2FePd(PdCl(DMAF)(py)),Mr = 463. 08,monoclinic,P21/n, a=10. 498(3),b=12. 082(8) ,c= 14. 487(9) A ,β= 106. 08(4)°, V= 1765. 8A3,Z = 4,Dc=1. 74g·cm-3. The final refinement converged with R=0. 051 and Rw = 0. 075 for 3277 observed reflections with I≥3σ( I ). The complex possesses a cyclo-palladated ferrocene with a a bonded Pd-C.     

SYNTHESIS AND CRYSTAL STRUCTURE OF V ^（v）O[N（CH2Ch2O）3]

<正> Reaction of ammonium metavanadate with triethanolamine in ethanol yields the title compound (2,2' , 2"-nitrilotriethoxy)oxo-vanadium (Ⅴ ). The crystal and molecular structure has been determined crystallographically. The complex V(v) O[N(CH2CH2O)3] crystallzes in the monoclinic system, space group P21, a = 7.140(1), 6 = 7.474(2), c=8.040(2) A ,β=92. 48(2)°, V=428. 7(1) A3, Mr= 213.1, Z = 2, F(000) = 220,μ= 10. 95cm-1, Dc= 1. 65gcm-3, final R= 0. 032 and Rw = 0. 034 based on 758 independant reflections with I>2σ(I). The vanadium center is in a distorted trigonal bipyramidal environment of a quadridentate chelating ligand and a terminal oxygen atom.     

SYNTHESIS AND CRYSTAL STRUCTURE OF A NEW BINUCLEAR CUPRUM COMPLEX, [(CuCl)_2(η~2-dppe)_2(μ-dppe)]·2CH_2C1_2

<正> C80H76Cl6Cu2P6,Mr=1563.13,monoclinic,P21/n,a=12.608(9),b=21.729(7),c=14.473(8)A.,β=105.34(5)°,V=3823.6A3,Z=2,Dc=1.28 g.cm-3,F(000)=1528,μ=8.6 cm-1,The final R and Rw are 0.076 and 0.083 respectively for 4418 observed reflections with I≥3σ(I).There is a center of inversion in the molecule.     

Studies on the V－Cu－S Heterometallic Cluster Compounds（2）．Crystal Structure of［VS_4（CuPPh_3）_5Br_2］·0．5CH_2Cl_2

ＳｔｕｄｉｅｓｏｎｔｈｅＶ－Ｃｕ－ＳＨｅｔｅｒｏｍｅｔａｌｌｉｃＣｌｕｓｔｅｒＣｏｍｐｏｕｎｄｓ（２）．ＣｒｙｓｔａｌＳｔｒｕｃｔｕｒｅｏｆ［ＶＳ_４（ＣｕＰＰｈ_３）_５Ｂｒ_２］·０．５ＣＨ_２Ｃｌ_２ＺｈｅｎｇＦａ－Ｋｕｎ；ＹｕＸｉｕ－Ｆｅｎ（Ｓｔａ...